>
Reinventing Reality on All Things Russia and Ukraine
Straight-Talk Candor v. Duplicitous Double-Talk
SIG SAUER MCX Virtus Conversion Kit First Impressions with Navy SEAL "Coch"
What's EASIER? MILKING a MINI COW or FULL SIZED COW?
Fully Charged Checks Out Aptera, Drives The Three-Wheeler Solar EV
This Man Built His Own ISP. Now He's Getting $2.6M to Expand It
Blowhole wave energy generator exceeds expectations in 12-month test
3-wheeled EV commuter equals 230 MPGe, blends torque & safety
Starlink Wins FCC Approval For In-Motion Use On Airplanes And Cruise Ships
Raspberry Pi Foundation brings Wi-Fi to Pico microcontroller
Have You Changed Phones Yet?, + Q&A
Breakthrough Zero-Carbon Fertilizer Set to Take Root Across the World as 'Biochar'
Artificial Photosynthesis Can Produce More Food in the Dark Than With Sunshine
Unapproved FDA anti-psychotics prescription drugs have been prescribed for two-year-olds who supposedly have bipolar disorder. On the record with Johnson and Johnson internal documents that have been uprooted, a certain doctor, who happens to be the chief of pediatric psychopharmacology at Harvard's Massachusetts General Hospital, appears to have pushed these unapproved drugs through speaking engagement fees for over $1.6 million, for a period of seven years, several years back.
One Joseph L. Biederman, with deep (filled) pockets and extensive ties to J&J, is a consultant who may be guilty of pushing psychotropic drugs that are prescribed for toddlers who go from crying to happy, and back to crying, too much. Isn't that just called the "terrible twos?" Since when do 2-year olds need toxic drugs that give them thoughts of suicide because they're moody?